These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 11162660
1. Study of multi-drug resistant mechanisms in a taxol-resistant hepatocellular carcinoma QGY-TR 50 cell line. Zhou J, Cheng SC, Luo D, Xie Y. Biochem Biophys Res Commun; 2001 Feb 09; 280(5):1237-42. PubMed ID: 11162660 [Abstract] [Full Text] [Related]
2. P-glycoprotein expression induced by glucose depletion enhanced the chemosensitivity in human hepatocellular carcinoma cell-lines. Cheng SC, Zhou J, Xie Y. Cell Biol Int; 2005 Apr 09; 29(4):269-75. PubMed ID: 15914037 [Abstract] [Full Text] [Related]
3. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma. Kumar A, Soprano DR, Parekh HK. Cancer Res; 2001 Oct 15; 61(20):7552-5. PubMed ID: 11606393 [Abstract] [Full Text] [Related]
10. Characterization and resistance mechanisms of cisplatin-resistant human hepatocellular carcinoma cell line. Yang JX, Luo Y, Qiu HM, Tang WX. Saudi Med J; 2009 Jan 15; 30(1):35-40. PubMed ID: 19139770 [Abstract] [Full Text] [Related]
11. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells. Ranganathan S, McCauley RA, Dexter DW, Hudes GR. Br J Cancer; 2001 Sep 01; 85(5):735-40. PubMed ID: 11531260 [Abstract] [Full Text] [Related]
12. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1. Chen YB, Yan ML, Gong JP, Xia RP, Liu LX, Li N, Lu SC, Zhang JG, Zeng DB, Xie JG, Yang JY, Yan LN. Chin Med J (Engl); 2007 Apr 20; 120(8):703-7. PubMed ID: 17517188 [Abstract] [Full Text] [Related]
14. Differential regulation of the cytotoxicity activity of paclitaxel by orobol and platelet derived growth factor in human ovarian carcinoma cells. Isonishi S, Saitou M, Saitou M, Yasuda M, Tanaka T. Oncol Rep; 2007 Jul 20; 18(1):195-201. PubMed ID: 17549368 [Abstract] [Full Text] [Related]
15. Relationship of multidrug resistance to rhodamine-123 selectivity between carcinoma and normal epithelial cells: taxol and vinblastine modulate drug efflux. Brouty-Boyé D, Kolonias D, Wu CJ, Savaraj N, Lampidis TJ. Cancer Res; 1995 Apr 15; 55(8):1633-8. PubMed ID: 7712466 [Abstract] [Full Text] [Related]
16. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity. Sulová Z, Macejová D, Seres M, Sedlák J, Brtko J, Breier A. Toxicol In Vitro; 2008 Feb 15; 22(1):96-105. PubMed ID: 17920233 [Abstract] [Full Text] [Related]
17. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5. Park SJ, Wu CH, Choi MR, Najafi F, Emami A, Safa AR. Biochem Pharmacol; 2006 Jul 28; 72(3):293-307. PubMed ID: 16753135 [Abstract] [Full Text] [Related]
18. Taxol induced Bcl-2 protein phosphorylation in human hepatocellular carcinoma QGY-7703 cell line. Cheng SC, Luo D, Xie Y. Cell Biol Int; 2001 Jul 28; 25(3):261-5. PubMed ID: 11352500 [Abstract] [Full Text] [Related]
19. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents. Ihnat MA, Lariviere JP, Warren AJ, La Ronde N, Blaxall JR, Pierre KM, Turpie BW, Hamilton JW. Clin Cancer Res; 1997 Aug 28; 3(8):1339-46. PubMed ID: 9815817 [Abstract] [Full Text] [Related]
20. [Establishment of a cisplatin-induced human hepatocellular carcinoma drug-resistant cell line and its biological characteristics]. Yang JX, Tang WX. Ai Zheng; 2002 Aug 28; 21(8):872-6. PubMed ID: 12478896 [Abstract] [Full Text] [Related] Page: [Next] [New Search]